NCT04073680 A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT04072952 A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04072718 Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT04072393 Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers Status TERMINATED Phase NA
NCT04069884 RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer Status RECRUITING Phase NA
NCT04068090 Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer Status UNKNOWN Phase N/A
NCT04066790 Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Status TERMINATED Phase PHASE2
NCT04060862 A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer Status TERMINATED Phase PHASE1
NCT04059809 Photobiomodulation for Breast Cancer Radiodermatitis Status COMPLETED Phase PHASE2/PHASE3
NCT04054986 Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer Status COMPLETED Phase PHASE1
NCT04050423 Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses Status RECRUITING Phase N/A
NCT04050228 Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer Status RECRUITING Phase NA
NCT04047758 Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer Status UNKNOWN Phase PHASE3